|
HU228769B1
(en)
*
|
1996-07-24 |
2013-05-28 |
Celgene Corp |
Substituted 2(2,6-dioxopiperidin-3-yl)phthalimides and -1-oxoisoindolines and their use for production of pharmaceutical compositions for mammals to reduce the level of tnf-alpha
|
|
US7517880B2
(en)
|
1997-12-22 |
2009-04-14 |
Bayer Pharmaceuticals Corporation |
Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
|
|
US7329670B1
(en)
|
1997-12-22 |
2008-02-12 |
Bayer Pharmaceuticals Corporation |
Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
|
|
US8124630B2
(en)
|
1999-01-13 |
2012-02-28 |
Bayer Healthcare Llc |
ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
|
EP1140840B1
(en)
*
|
1999-01-13 |
2006-03-22 |
Bayer Pharmaceuticals Corp. |
-g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
|
EP1158985B1
(en)
*
|
1999-01-13 |
2011-12-28 |
Bayer HealthCare LLC |
OMEGA-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS
|
|
ME00275B
(me)
|
1999-01-13 |
2011-02-10 |
Bayer Corp |
ω-KARBOKSIARIL SUPSTITUISANI DIFENIL KARBAMIDI KAO INHIBITORI RAF KINAZE
|
|
ATE278674T1
(de)
*
|
1999-03-12 |
2004-10-15 |
Boehringer Ingelheim Pharma |
Heterocyklischer harnstoff und verwandte verbindungen als entzündungshemmende mittel
|
|
EP1466906A1
(en)
*
|
1999-03-12 |
2004-10-13 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Heterocyclic urea and related compounds useful as anti-inflammatory agents
|
|
US7629360B2
(en)
|
1999-05-07 |
2009-12-08 |
Celgene Corporation |
Methods for the treatment of cachexia and graft v. host disease
|
|
CA2374737C
(en)
*
|
1999-07-09 |
2008-02-12 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Novel process for synthesis of heteroaryl-substituted urea compounds
|
|
EP1232150B1
(en)
*
|
1999-11-16 |
2007-10-10 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Urea derivatives as anti-inflammatory agents
|
|
US6635767B2
(en)
*
|
2000-05-23 |
2003-10-21 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Synthesis of heteroarylamine intermediate compounds
|
|
US6822093B2
(en)
|
2000-05-23 |
2004-11-23 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Synthesis of heteroarylamine intermediate compounds
|
|
US7235576B1
(en)
|
2001-01-12 |
2007-06-26 |
Bayer Pharmaceuticals Corporation |
Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
|
EP1362037A1
(en)
|
2001-02-15 |
2003-11-19 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Process for synthesis of heteroaryl-substituted urea compounds useful as antiinflammatory agents
|
|
US6949585B2
(en)
|
2001-04-03 |
2005-09-27 |
Eisai Co., Ltd. |
Cyclooctanone derivatives and cyclodecanone derivative, and use thereof
|
|
WO2002083642A1
(en)
*
|
2001-04-13 |
2002-10-24 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Compounds useful as anti-inflammatory agents
|
|
US7371763B2
(en)
*
|
2001-04-20 |
2008-05-13 |
Bayer Pharmaceuticals Corporation |
Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
|
|
JP2004530690A
(ja)
*
|
2001-05-16 |
2004-10-07 |
ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド |
抗炎症性薬剤として有用なジアリールウレア誘導体
|
|
EP1935885A3
(en)
*
|
2001-05-22 |
2008-10-15 |
Neurogen Corporation |
Melanin concentrating hormone receptor ligands : substituted 1-benzyl-4-aryl piperazine analogues.
|
|
CA2448080A1
(en)
*
|
2001-05-22 |
2002-11-28 |
Neurogen Corporation |
Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
|
|
EP1395561A1
(en)
*
|
2001-05-25 |
2004-03-10 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Carbamate and oxamide compounds as inhibitors of cytokine production
|
|
EP1414810B1
(en)
|
2001-06-05 |
2006-08-30 |
Boehringer Ingelheim Pharmaceuticals Inc. |
1,4-disubstituted benzo-fused cycloalkyl urea compounds
|
|
US6881741B2
(en)
*
|
2001-06-11 |
2005-04-19 |
Virochem Pharma Inc. |
Compounds and methods for the treatment or prevention of Flavivirus infections
|
|
US8329924B2
(en)
*
|
2001-06-11 |
2012-12-11 |
Vertex Pharmaceuticals (Canada) Incorporated |
Compounds and methods for the treatment or prevention of Flavivirus infections
|
|
ES2266553T3
(es)
|
2001-06-29 |
2007-03-01 |
Ab Science |
Utilizacion de derivados de la n-fenil-2-pirimidina-amina para tratar las enfermedades inflamatorias.
|
|
ES2274993T3
(es)
|
2001-06-29 |
2007-06-01 |
Ab Science |
Utilizacion de inhibidores de tirosina cinasa para el tratamiento de enfermedades alergicas.
|
|
WO2003003006A2
(en)
|
2001-06-29 |
2003-01-09 |
Ab Science |
New potent, selective and non toxic c-kit inhibitors
|
|
EP1401411A2
(en)
*
|
2001-06-29 |
2004-03-31 |
AB Science |
Use of tyrosine kinase inhibitors for treating bone loss
|
|
JP2004537542A
(ja)
|
2001-06-29 |
2004-12-16 |
アブ サイエンス |
炎症性腸疾患（ｉｂｄ）を治療するための、チロシンキナーゼ阻害剤の使用
|
|
EP1709965A3
(en)
|
2001-07-11 |
2006-12-27 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Methods of treating cytokine mediate diseases
|
|
US6603000B2
(en)
|
2001-07-11 |
2003-08-05 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Synthesis for heteroarylamine compounds
|
|
PT1414800E
(pt)
*
|
2001-07-11 |
2005-04-29 |
Boehringer Ingelheim Pharma |
Nova sintese de compostos de heteroarilamina
|
|
WO2003005999A2
(en)
|
2001-07-11 |
2003-01-23 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Methods of treating cytokine mediated diseases
|
|
WO2003022273A1
(en)
*
|
2001-09-13 |
2003-03-20 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Methods of treating cytokine mediated diseases
|
|
MY138086A
(en)
|
2001-09-13 |
2009-04-30 |
Smithkline Beecham Plc |
Novel urea derivative as vanilloid receptor-1 antagonist
|
|
EP1438048A1
(en)
*
|
2001-10-18 |
2004-07-21 |
Boehringer Ingelheim Pharmaceuticals Inc. |
1,4-disubstituted benzo-fused urea compounds as cytokine inhibitors
|
|
US20080108672A1
(en)
*
|
2002-01-11 |
2008-05-08 |
Bernd Riedl |
Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors
|
|
ATE529406T1
(de)
|
2002-02-11 |
2011-11-15 |
Bayer Healthcare Llc |
Aryl-harnstoffe als kinase inhibitoren
|
|
SI1478358T1
(sl)
|
2002-02-11 |
2013-09-30 |
Bayer Healthcare Llc |
Sorafenib tozilat za zdravljenje bolezni, značilnih po abnormalni angiogenezi
|
|
WO2003068229A1
(en)
|
2002-02-11 |
2003-08-21 |
Bayer Pharmaceuticals Corporation |
Pyridine, quinoline, and isoquinoline n-oxides as kinase inhibitors
|
|
EP1480973B1
(en)
|
2002-02-25 |
2008-02-13 |
Boehringer Ingelheim Pharmaceuticals Inc. |
1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases
|
|
CA2479520A1
(en)
*
|
2002-04-05 |
2003-10-16 |
Birgit Jung |
P38 kinase inhibitors for treating mucus hypersecretion_
|
|
US20030225089A1
(en)
*
|
2002-04-10 |
2003-12-04 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors
|
|
ATE469142T1
(de)
*
|
2002-04-11 |
2010-06-15 |
Boehringer Ingelheim Pharma |
Heterocyclische amid-derivate als cytokin- inhibitoren
|
|
US20030236287A1
(en)
*
|
2002-05-03 |
2003-12-25 |
Piotrowski David W. |
Positive allosteric modulators of the nicotinic acetylcholine receptor
|
|
EP1551793B1
(en)
*
|
2002-06-19 |
2016-01-20 |
AmKor Pharma, Inc. |
Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same
|
|
ES2278170T3
(es)
*
|
2002-07-09 |
2007-08-01 |
BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG |
Composiciones farmaceuticas de anticolinergicos e inhibidores de la quinasa p38 en el tratamiento de enfermedades respiratorias.
|
|
US20040044020A1
(en)
*
|
2002-07-09 |
2004-03-04 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Pharmaceutical compositions based on novel anticholinergics and p38 kinase inhibitors
|
|
EP1549621A1
(en)
*
|
2002-08-08 |
2005-07-06 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Fluorinated phenyl-naphthalenyl-urea compounds as inhibitors of cytokines involved in inflammatory processes
|
|
US7232828B2
(en)
|
2002-08-10 |
2007-06-19 |
Bethesda Pharmaceuticals, Inc. |
PPAR Ligands that do not cause fluid retention, edema or congestive heart failure
|
|
US20040110755A1
(en)
*
|
2002-08-13 |
2004-06-10 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Combination therapy with p38 MAP kinase inhibitors and their pharmaceutical compositions
|
|
JP2006500365A
(ja)
*
|
2002-08-14 |
2006-01-05 |
ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド |
ｐ３８ＭＡＰキナーゼインヒビターを用いた抗凝固及び線維素溶解療法
|
|
US7179836B2
(en)
*
|
2002-09-20 |
2007-02-20 |
Smithkline Beecham Corporation |
Chemical compounds
|
|
US7202259B2
(en)
|
2002-11-18 |
2007-04-10 |
Euro-Celtique S.A. |
Therapeutic agents useful for treating pain
|
|
WO2004048389A1
(en)
*
|
2002-11-22 |
2004-06-10 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Preparation of aryl intermediates compounds using trialkylmagnesate reagents
|
|
KR101058696B1
(ko)
*
|
2002-12-10 |
2011-08-22 |
바이로켐 파마 인코포레이티드 |
후라비바이러스 감염의 치료 또는 예방을 위한 화합물과방법
|
|
US7202257B2
(en)
|
2003-12-24 |
2007-04-10 |
Deciphera Pharmaceuticals, Llc |
Anti-inflammatory medicaments
|
|
US7144911B2
(en)
*
|
2002-12-31 |
2006-12-05 |
Deciphera Pharmaceuticals Llc |
Anti-inflammatory medicaments
|
|
US7557129B2
(en)
|
2003-02-28 |
2009-07-07 |
Bayer Healthcare Llc |
Cyanopyridine derivatives useful in the treatment of cancer and other disorders
|
|
US7135575B2
(en)
*
|
2003-03-03 |
2006-11-14 |
Array Biopharma, Inc. |
P38 inhibitors and methods of use thereof
|
|
US7521447B2
(en)
*
|
2003-03-03 |
2009-04-21 |
Array Biopharma Inc. |
P38 inhibitors and methods of use thereof
|
|
KR100767854B1
(ko)
|
2003-03-12 |
2007-10-17 |
화이자 프로덕츠 인크. |
피리딜옥시메틸 및 벤즈이속사졸 아자비시클릭 유도체
|
|
GB2400101A
(en)
*
|
2003-03-28 |
2004-10-06 |
Biofocus Discovery Ltd |
Compounds capable of binding to the active site of protein kinases
|
|
WO2004101529A1
(ja)
*
|
2003-05-19 |
2004-11-25 |
Ono Pharmaceutical Co., Ltd. |
含窒素複素環化合物およびその医薬用途
|
|
EP1636585B2
(en)
|
2003-05-20 |
2012-06-13 |
Bayer HealthCare LLC |
Diaryl ureas with kinase inhibiting activity
|
|
EP1663978B1
(en)
*
|
2003-07-23 |
2007-11-28 |
Bayer Pharmaceuticals Corporation |
Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions
|
|
CA2536293A1
(en)
*
|
2003-08-22 |
2005-03-03 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Methods of treating copd and pulmonary hypertension
|
|
KR100886002B1
(ko)
*
|
2004-01-30 |
2009-03-03 |
유로-셀띠끄 소시에떼 아노님 |
4-테트라졸릴-4-페닐피페리딘 화합물의 제조방법
|
|
EP2295426A1
(en)
*
|
2004-04-30 |
2011-03-16 |
Bayer HealthCare, LLC |
Substituted pyrazolyl urea derivatives useful in the treatment of cancer
|
|
US7550499B2
(en)
*
|
2004-05-12 |
2009-06-23 |
Bristol-Myers Squibb Company |
Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
|
|
PT1761520E
(pt)
*
|
2004-06-23 |
2008-09-15 |
Lilly Co Eli |
Inibidores de quinase
|
|
US20060035893A1
(en)
|
2004-08-07 |
2006-02-16 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
|
|
AU2005286728A1
(en)
|
2004-09-20 |
2006-03-30 |
Xenon Pharmaceuticals Inc. |
Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase
|
|
AU2005286647A1
(en)
|
2004-09-20 |
2006-03-30 |
Xenon Pharmaceuticals Inc. |
Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
|
|
BRPI0515500A
(pt)
|
2004-09-20 |
2008-07-29 |
Xenon Pharmaceuticals Inc |
derivados piridazina para inibição de estearoil-coa-desaturase
|
|
BRPI0515482A
(pt)
|
2004-09-20 |
2008-07-22 |
Xenon Pharmaceuticals Inc |
derivados heterocìclicos e seus usos como agentes terapêuticos
|
|
MX2007003318A
(es)
|
2004-09-20 |
2007-05-18 |
Xenon Pharmaceuticals Inc |
Derivados heterociclicos y su uso como agentes terapeuticos.
|
|
CN101084211A
(zh)
|
2004-09-20 |
2007-12-05 |
泽农医药公司 |
杂环衍生物及其作为治疗剂的用途
|
|
MX2007003332A
(es)
|
2004-09-20 |
2007-06-05 |
Xenon Pharmaceuticals Inc |
Derivados heterociclicos y su uso como inhibidores de estearoil-coa-desaturasa.
|
|
US7741479B2
(en)
*
|
2004-12-07 |
2010-06-22 |
Locus Pharmaceuticals, Inc. |
Urea inhibitors of MAP kinases
|
|
US7612200B2
(en)
*
|
2004-12-07 |
2009-11-03 |
Locus Pharmaceuticals, Inc. |
Inhibitors of protein kinases
|
|
PE20060777A1
(es)
|
2004-12-24 |
2006-10-06 |
Boehringer Ingelheim Int |
Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
|
|
WO2006078621A2
(en)
*
|
2005-01-19 |
2006-07-27 |
Bristol-Myers Squibb Company |
2-phenoxy-n- (1, 3 , 4-thiadizol-2-yl) pyridin-3-amine derivatives and related compounds as p2y1 receptor inhibitors for the treatment of thromboembolic disorders
|
|
WO2006119646A1
(en)
*
|
2005-05-13 |
2006-11-16 |
Virochem Pharma Inc. |
Compounds and methods for the treatment or prevention of flavivirus infections
|
|
PL1891075T3
(pl)
*
|
2005-05-24 |
2011-12-30 |
Merck Serono Sa |
Spiropochodne tricykliczne jako modulatory CRTH2
|
|
CA2618646A1
(en)
|
2005-06-03 |
2007-11-15 |
Xenon Pharmaceuticals Inc. |
Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
|
|
ATE502924T1
(de)
|
2005-06-27 |
2011-04-15 |
Bristol Myers Squibb Co |
Lineare harnstoffmimetika-antagonisten des p2y1- rezeptors zur behandlung von thromboseleiden
|
|
DE602006017694D1
(de)
*
|
2005-06-27 |
2010-12-02 |
Bristol Myers Squibb Co |
C-verknüpfte zyklische antagonisten des p2y1-rezeptors mit eignung bei der behandlung thrombotischer leiden
|
|
WO2007002634A1
(en)
*
|
2005-06-27 |
2007-01-04 |
Bristol-Myers Squibb Company |
Carbocycle and heterocycle antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
|
|
TW200726764A
(en)
*
|
2005-06-27 |
2007-07-16 |
Bristol Myers Squibb Co |
N-linked heterocyclic antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
|
|
DE102005037499A1
(de)
*
|
2005-08-09 |
2007-02-15 |
Merck Patent Gmbh |
Pyrazolderivate
|
|
US20070049565A1
(en)
*
|
2005-08-24 |
2007-03-01 |
Neurotech Pharmaceuticals Co., Ltd. |
Combination of cell necrosis inhibitor and lithium for treating neuronal death or neurological dysfunction
|
|
US20070298129A1
(en)
*
|
2005-08-24 |
2007-12-27 |
Neurotech Pharmaceuticals Co., Ltd. |
Compounds and compositions for treating neuronal death or neurological dysfunction
|
|
US7714127B2
(en)
*
|
2005-10-06 |
2010-05-11 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Process for making heteroaryl amine intermediate compounds
|
|
US20070185098A1
(en)
*
|
2006-01-04 |
2007-08-09 |
Locus Pharmaceuticals, Inc. |
Inhibitors of protein kinases
|
|
RS52298B
(sr)
*
|
2006-01-31 |
2012-12-31 |
Array Biopharma Inc. |
Inhibitori kinaze i postupak njihove upotrebe
|
|
WO2007109434A1
(en)
*
|
2006-03-17 |
2007-09-27 |
Boehringer Ingelheim International Gmbh |
Besylate salt form of 1- (5-tert-butyl-2-p-t0lyl-2h-pyraz0l-3-yl) -3- (4- (6- (morpholin-4-yl-methyl) -pyrid in- 3 -yl) -naphthalen- 1-yl) -urea and polymorphs thereof
|
|
US7960569B2
(en)
*
|
2006-10-17 |
2011-06-14 |
Bristol-Myers Squibb Company |
Indole antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
|
|
JP5290186B2
(ja)
*
|
2006-11-15 |
2013-09-18 |
ヴァイロケム ファーマ インコーポレイテッド |
フラビウイルス感染症の治療または予防用のチオフェン類似体
|
|
EP1992344A1
(en)
|
2007-05-18 |
2008-11-19 |
Institut Curie |
P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation
|
|
KR100852962B1
(ko)
*
|
2007-11-12 |
2008-08-20 |
주식회사 뉴로테크 |
2-하이드록시-5-페닐알킬아미노벤조산 유도체 및 이의 염의제조방법
|
|
AR069650A1
(es)
*
|
2007-12-14 |
2010-02-10 |
Actelion Pharmaceuticals Ltd |
Derivados de aminopirazol como agonistas no peptidicos del receptor alx humano
|
|
MX2010007419A
(es)
|
2008-01-04 |
2010-11-12 |
Intellikine Inc |
Ciertas entidades quimicas, composiciones y metodos.
|
|
US8193182B2
(en)
|
2008-01-04 |
2012-06-05 |
Intellikine, Inc. |
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
|
|
PL2242749T3
(pl)
*
|
2008-02-05 |
2013-09-30 |
Hoffmann La Roche |
Nowe pirydynony i pirydazynony
|
|
ES2564454T3
(es)
*
|
2009-03-09 |
2016-03-22 |
Taiho Pharmaceutical Co., Ltd. |
Compuesto de piperazina que puede inhibir la prostaglandina D sintasa
|
|
GB0905955D0
(en)
|
2009-04-06 |
2009-05-20 |
Respivert Ltd |
Novel compounds
|
|
KR101713453B1
(ko)
|
2010-03-12 |
2017-03-07 |
오메로스 코포레이션 |
Pde10 억제제 및 관련 조성물 및 방법
|
|
US9024041B2
(en)
|
2010-04-08 |
2015-05-05 |
Respivert Ltd. |
P38 MAP kinase inhibitors
|
|
WO2011158044A2
(en)
|
2010-06-17 |
2011-12-22 |
Respivert Limited |
Respiratory formulations and compounds for use therein
|
|
ES2637113T3
(es)
|
2011-01-10 |
2017-10-10 |
Infinity Pharmaceuticals, Inc. |
Procedimientos para preparar isoquinolinonas y formas sólidas de isoquinolinonas
|
|
ES2659763T3
(es)
*
|
2011-02-14 |
2018-03-19 |
The Regents Of The University Of Michigan |
Composiciones y procedimientos para el tratamiento de obesidad y trastornos relacionados
|
|
US8809372B2
(en)
|
2011-09-30 |
2014-08-19 |
Asana Biosciences, Llc |
Pyridine derivatives
|
|
US9199975B2
(en)
|
2011-09-30 |
2015-12-01 |
Asana Biosciences, Llc |
Biaryl imidazole derivatives for regulating CYP17
|
|
US8476303B2
(en)
*
|
2011-10-31 |
2013-07-02 |
Florida A&M University Board of Trustees |
N-aminopyrrolylmethyltetrahydropyridines as anti-cancer agents
|
|
US8461179B1
(en)
|
2012-06-07 |
2013-06-11 |
Deciphera Pharmaceuticals, Llc |
Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
|
|
US8828998B2
(en)
|
2012-06-25 |
2014-09-09 |
Infinity Pharmaceuticals, Inc. |
Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors
|
|
EP2890460B1
(en)
|
2012-08-29 |
2017-02-22 |
Respivert Limited |
Kinase inhibitors
|
|
US9783556B2
(en)
|
2012-08-29 |
2017-10-10 |
Respivert Limited |
Kinase inhibitors
|
|
US20150225373A1
(en)
|
2012-08-29 |
2015-08-13 |
Respivert Limited |
Kinase inhibitors
|
|
AU2013337717B2
(en)
|
2012-11-01 |
2018-10-25 |
Infinity Pharmaceuticals, Inc. |
Treatment of cancers using PI3 kinase isoform modulators
|
|
AU2014246866B2
(en)
|
2013-04-02 |
2018-05-10 |
Oxular Acquisitions Limited |
Kinase inhibitor
|
|
EP2981534B1
(en)
|
2013-04-02 |
2017-07-19 |
Topivert Pharma Limited |
Kinase inhibitors based upon n-alkyl pyrazoles
|
|
EP2991647B1
(en)
|
2013-05-02 |
2019-04-24 |
The Regents Of The University Of Michigan |
Deuterated amlexanox with improved metabolic stability
|
|
CA2934199A1
(en)
|
2013-12-20 |
2015-06-25 |
Respivert Limited |
Urea derivatives useful as kinase inhibitors
|
|
WO2015160975A2
(en)
|
2014-04-16 |
2015-10-22 |
Infinity Pharmaceuticals, Inc. |
Combination therapies
|
|
NZ716494A
(en)
|
2014-04-28 |
2017-07-28 |
Omeros Corp |
Processes and intermediates for the preparation of a pde10 inhibitor
|
|
NZ630803A
(en)
|
2014-04-28 |
2016-03-31 |
Omeros Corp |
Optically active pde10 inhibitor
|
|
MA40774A
(fr)
|
2014-10-01 |
2017-08-08 |
Respivert Ltd |
Dérivés de diaryle-urée en tant qu'inhibiteurs de kinase p38
|
|
KR20170139074A
(ko)
|
2015-04-24 |
2017-12-18 |
오메로스 코포레이션 |
Pde10 억제제 및 관련 조성물 및 방법
|
|
WO2017079678A1
(en)
|
2015-11-04 |
2017-05-11 |
Omeros Corporation |
Solid state forms of a pde10 inhibitor
|
|
EP3407974A4
(en)
|
2016-01-29 |
2019-08-28 |
The Regents Of The University Of Michigan |
Amlexanox Analogs
|
|
EA201892213A1
(ru)
|
2016-04-06 |
2019-05-31 |
Топайверт Фарма Лимитед |
Ингибиторы киназ
|
|
SG11201811237WA
(en)
|
2016-06-24 |
2019-01-30 |
Infinity Pharmaceuticals Inc |
Combination therapies
|
|
CN106632403B
(zh)
*
|
2017-01-23 |
2018-09-11 |
牡丹江医学院 |
一种手术用止痛消炎药及其制备方法
|
|
US10364245B2
(en)
|
2017-06-07 |
2019-07-30 |
Chiesi Farmaceutici S.P.A. |
Kinase inhibitors
|
|
WO2019126731A1
(en)
|
2017-12-22 |
2019-06-27 |
Petra Pharma Corporation |
Aminopyridine derivatives as phosphatidylinositol phosphate kinase inhibitors
|
|
IL276398B2
(en)
|
2018-01-31 |
2026-03-01 |
Deciphera Pharmaceuticals Llc |
Combination therapy for mastocytosis
|
|
CN118416236A
(zh)
|
2018-01-31 |
2024-08-02 |
德西费拉制药有限责任公司 |
治疗胃肠道间质瘤的组合疗法
|
|
WO2020185812A1
(en)
|
2019-03-11 |
2020-09-17 |
Teva Pharmaceuticals International Gmbh |
Solid state forms of ripretinib
|
|
TW202112767A
(zh)
|
2019-06-17 |
2021-04-01 |
美商佩特拉製藥公司 |
作為磷脂酸肌醇磷酸激酶抑制劑之胺基吡啶衍生物
|
|
TWI878335B
(zh)
|
2019-08-12 |
2025-04-01 |
美商迪賽孚爾製藥有限公司 |
治療胃腸道基質瘤方法
|
|
EP4013412B1
(en)
|
2019-08-12 |
2026-01-28 |
Deciphera Pharmaceuticals, LLC |
Ripretinib for treating gastrointestinal stromal tumors
|
|
MX2022008103A
(es)
|
2019-12-30 |
2022-09-19 |
Deciphera Pharmaceuticals Llc |
Formulaciones de inhibidores de la cinasa amorfa y metodos de estas.
|
|
EP4084779B1
(en)
|
2019-12-30 |
2024-10-09 |
Deciphera Pharmaceuticals, LLC |
Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea
|
|
CA3174623A1
(en)
*
|
2020-03-05 |
2021-09-10 |
Janpix, Ltd. |
Stat inhibitory compounds and compositions
|
|
US11779572B1
(en)
|
2022-09-02 |
2023-10-10 |
Deciphera Pharmaceuticals, Llc |
Methods of treating gastrointestinal stromal tumors
|
|
CN116987041A
(zh)
*
|
2023-08-02 |
2023-11-03 |
河北科技大学 |
一种转移氢化法制备5-(2-氨基-4-氯苯基)四氮唑的方法
|